Blood Cancer R&D summit 2018
An exclusive, annual biopharma conference providing insights into the research and development of cutting edge treatments for Blood Cancer and a networking forum for precision medicine leaders in this space.
Blood Cancer accounts for 10% of new cancer cases diagnosed in the US in 2017. Approximately every 3 minutes one person is diagnosed and every 9 minutes one person dies.
Blood cancer R&D is experiencing rapid growth, representing an enormous opportunity for drug developers, driven by Innovative Cancer Treatment Therapies
The global market for Blood cancer therapeutics, valued at $24 billion in 2015, is poised to reach $38 billion by 2020, expanding by a CAGR of 9.7%
Event Properties
Event Date | 18 Sep 2018 |
Event End Date | 19 Sep 2018 |
Registration Start Date | 10 Apr 2018 |
Capacity | 3000 |
Available place | 3000 |
Name of the Organizer: | Neo-Synth Ltd. |
Person of Contact | Kevin |
Location | San Francisco |